Yu M - Search Results

1

Gefitinib in patients with chemo-sensitive and chemo-refractory relapsed small cell cancers: a Hoosier Oncology Group phase II trial.

Moore AM, Einhorn LH, Estes D, Govindan R, Axelson J, Vinson J, Breen TE, Yu M, Hanna NH. Moore AM, et al. Among authors: yu m. Lung Cancer. 2006 Apr;52(1):93-7. doi: 10.1016/j.lungcan.2005.12.002. Epub 2006 Feb 20. Lung Cancer. 2006. PMID: 16488055 Clinical Trial.

2

Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer.

Hammoud ZT, Kesler KA, Ferguson MK, Battafarrano RJ, Bhogaraju A, Hanna N, Govindan R, Mauer AA, Yu M, Einhorn LH. Hammoud ZT, et al. Among authors: yu m. Dis Esophagus. 2006;19(2):69-72. doi: 10.1111/j.1442-2050.2006.00542.x. Dis Esophagus. 2006. PMID: 16643172

3

A phase I and pharmacokinetic trial of erlotinib in combination with weekly docetaxel in patients with taxane-naive malignancies.

Chiorean EG, Porter JM, Foster AE, Al Omari AS, Yoder CA, Fife KL, Strother RM, Murry DJ, Yu M, Jones DR, Sweeney CJ. Chiorean EG, et al. Among authors: yu m. Clin Cancer Res. 2008 Feb 15;14(4):1131-7. doi: 10.1158/1078-0432.CCR-07-0437. Clin Cancer Res. 2008. PMID: 18281547 Clinical Trial.

4

Gefitinib plus celecoxib in chemotherapy-naïve patients with stage IIIB/IV non-small cell lung cancer: a phase II study from the Hoosier Oncology Group.

Agarwala A, Fisher W, Bruetman D, McClean J, Taber D, Titzer M, Juliar B, Yu M, Breen T, Einhorn LH, Hanna N. Agarwala A, et al. Among authors: yu m. J Thorac Oncol. 2008 Apr;3(4):374-9. doi: 10.1097/JTO.0b013e3181693869. J Thorac Oncol. 2008. PMID: 18379355 Free article. Clinical Trial.

5

Pemetrexed in second line and beyond small cell lung cancer: a Hoosier Oncology Group phase II study.

Jalal S, Ansari R, Govindan R, Bhatia S, Bruetman D, Fisher W, Masters G, White A, Stover D, Yu M, Hanna N; Hoosier Oncology Group. Jalal S, et al. Among authors: yu m. J Thorac Oncol. 2009 Jan;4(1):93-6. doi: 10.1097/JTO.0b013e31818de1e6. J Thorac Oncol. 2009. PMID: 19096313 Free article. Clinical Trial.

6

A phase II study of pemetrexed as second-line chemotherapy for the treatment of metastatic castrate-resistant prostate cancer (CRPC); Hoosier Oncology Group GU03-67.

Hahn NM, Zon RT, Yu M, Ademuyiwa FO, Jones T, Dugan W, Whalen C, Shanmugam R, Skaar T, Sweeney CJ. Hahn NM, et al. Among authors: yu m. Ann Oncol. 2009 Dec;20(12):1971-6. doi: 10.1093/annonc/mdp244. Epub 2009 Jul 15. Ann Oncol. 2009. PMID: 19605506 Free article. Clinical Trial.

7

Pemetrexed plus cetuximab in patients with recurrent non-small cell lung cancer (NSCLC): a phase I/II study from the Hoosier Oncology Group.

Jalal S, Waterhouse D, Edelman MJ, Nattam S, Ansari R, Koneru K, Clark R, Richards A, Wu J, Yu M, Bottema B, White A, Hanna N. Jalal S, et al. Among authors: yu m. J Thorac Oncol. 2009 Nov;4(11):1420-4. doi: 10.1097/JTO.0b013e3181b624ae. J Thorac Oncol. 2009. PMID: 19701110 Free article. Clinical Trial.

8

A phase I dose escalation and pharmacokinetic study of vatalanib (PTK787/ZK 222584) in combination with paclitaxel in patients with advanced solid tumors.

Chiorean EG, Malireddy S, Younger AE, Jones DR, Waddell MJ, Sloop MI, Yu M, Hall SD, Schneider B, Sweeney CJ. Chiorean EG, et al. Among authors: yu m. Cancer Chemother Pharmacol. 2010 Aug;66(3):441-8. doi: 10.1007/s00280-009-1179-2. Epub 2009 Nov 29. Cancer Chemother Pharmacol. 2010. PMID: 20091169 Clinical Trial.

9

Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel.

Barriger RB, Fakiris AJ, Hanna N, Yu M, Mantravadi P, McGarry RC. Barriger RB, et al. Among authors: yu m. Int J Radiat Oncol Biol Phys. 2010 Dec 1;78(5):1381-6. doi: 10.1016/j.ijrobp.2009.09.030. Epub 2010 Mar 16. Int J Radiat Oncol Biol Phys. 2010. PMID: 20231061 Clinical Trial.

10

A phase II study of gemcitabine in combination with radiation therapy in patients with localized, unresectable, pancreatic cancer: a Hoosier Oncology Group study.

Cardenes HR, Moore AM, Johnson CS, Yu M, Helft P, Chiorean EG, Vinson J, Howard TJ, Stephens AW, Tai DF, Loehrer PJ Sr. Cardenes HR, et al. Among authors: yu m. Am J Clin Oncol. 2011 Oct;34(5):460-5. doi: 10.1097/COC.0b013e3181e9c103. Am J Clin Oncol. 2011. PMID: 20881474 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,850 results

Search Page

Filters